Table S1 from AXL Mediates Cetuximab and Radiation Resistance Through Tyrosine 821 and the c-ABL Kinase Pathway in Head and Neck Cancer
DOI:
10.1158/1078-0432.22476615.v1
Publication Date:
2023-04-01T01:45:28Z
AUTHORS (20)
ABSTRACT
<p>Clinical characteristics of tumors</p>
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....